Join Us at Cosmopack Asia 2025
AM Biotech is honored to participate in Cosmopack Asia 2025, where we will present our
Oct
AM Biotech Wins Prestigious National Innovation Award, Pioneering Bio-Pulsed Exosome Research
AM Biotech, a pioneering force in bio-pulsed exosome research, has been honored with the 21st
Jan
AM Biotech joins forces with PITDC to advance biotech innovation and expand into the trillion-dollar pharmaceutical market.
Ascension Medical Biotechnology (AM BioTech), a leading domestic company specializing in exosome functional induction technology
Sep
AM Biotech Presents New Technologies and Products at Asia Healthcare & Medical Cosmetology Expo 2024
Biotechnology ✕ Beauty and Health "Asia Healthcare & Medical Cosmetology Expo 2024" showcases projects covering
Jun
Emerging Exosome Treatment Shines Hope on Chronic Kidney Disease and Renal Fibrosis
Chronic Kidney Disease (CKD) is increasingly recognized as a significant health concern worldwide. According to
May
AM Biotech Bio-Pulsed Exosomes entered the top 5 finalists pioneering innovation “Estée Lauder (NIV) BRKTHRU VOICES Prize” at 2024 in-Cosmetics Global
Ascension Medical Biotechnology Co. Ltd.” (AM BIOTECH) is a Taiwan medical biotechnology research company, producer
May
New Hope for Patients with Hearing Loss: Stem Cell-Derived Exosomes Show Potential for Repairing Cochlear Cells and Nerves
Risk factors for hearing loss include ear infections, prolonged exposure to high-frequency noise, and unhealthy
Apr
A Breakthrough in Osteoporosis Treatment! Harnessing Exosomes from Skeletal Muscles for Bone Healing
This groundbreaking study shines a light on the exosomes present in these muscle-secreted humoral factors.
Mar
Stem Cell Exosomes with Specific miRNAs: A New Frontier in Treating Male Pattern Baldness
As the exploration of exosomes in clinical settings progresses, there's growing anticipation for their integration
Mar
Can Exosomes Also Treat Dry Eye Syndrome?!
Biologically and medically speaking, immune cells activated after transplantation continuously attack hematopoietic tissues and ocular
Dec
- 1
- 2
